Isao Hara
Kimiidera, 6410012, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 318 publications
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer.
Journal: BJUI compass
Published: January 06, 2026
Impact of prior primary tumor resection on long-term prognosis in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab: a multicenter analysis.
Journal: International journal of clinical oncology
Published: December 28, 2025
Comparison of the da Vinci Xi and hinotori surgical robotic systems using a training model: an ex vivo study.
Journal: Journal of robotic surgery
Published: December 09, 2025
Cachexia index as a prognostic indicator in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab: multicenter analysis.
Journal: International journal of clinical oncology
Published: September 23, 2025
Report of the Advanced Prostate Cancer Consensus Conference-JAPAN 2025 at the 112th Annual Meeting of the Japanese Urological Association.
Journal: Translational andrology and urology
Published: September 18, 2025
Synchronous Bilateral Large Renal Cell Carcinoma Treated With Presurgical Pembrolizumab and Lenvatinib Enabling Unilateral Partial Nephrectomy and Dialysis Avoidance: A Case Report.
Journal: IJU case reports
Published: June 21, 2025
Extended pelvic lymphadenectomy does not improve biochemical recurrence in high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a propensity-matched comparison of two institutions.
Journal: Japanese journal of clinical oncology
Published: March 27, 2025
TMB-High, MSI-High Castration-Resistant Prostate Cancer Treated With Pembrolizumab.
Journal: IJU case reports
Published: March 10, 2025
Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis.
Journal: IJU case reports
Published: February 03, 2025
Serum Lactate Dehydrogenase Level Prior to First-Line Chemotherapy for Metastatic Urothelial Carcinoma Is a Prognostic Factor for Avelumab Maintenance Therapy: A Multicenter Retrospective Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: January 05, 2025
Efficacy and Safety of Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma in Patients 75 Years and Older: Multicenter Retrospective Study.
Journal: Cancers
Published: December 24, 2024
Last Updated: 09/26/2026